Loading...

APC anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-F11_APC_090507
C57BL/6 mouse splenocytes stained with 30-F11 APC
  • 30-F11_APC_090507
    C57BL/6 mouse splenocytes stained with 30-F11 APC
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
103111 25 µg 27€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103112 100 µg 76€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Witherel CE, et al. 2021. Biomaterials. 269:120667. PubMed
  2. Kozuki S, et al. 2022. Genes Cells. 27:192. PubMed
  3. Cautivo KM, et al. 2022. Immunity. 55:254. PubMed
  4. Liang X, et al. 2022. Cancer Commun (Lond). 42:205. PubMed
  5. Lloyd-Lewis B, et al. 2022. Cell Rep. 38:110461. PubMed
  6. Yang Y, et al. 2022. FEBS J. 289:5279. PubMed
  7. MacLean AJ, et al. 2022. Immunity. 55:718. PubMed
  8. Yousefi M, et al. 2022. Cancer Res. 82:1589. PubMed
  9. Van Deren DA, et al. 2022. Development. 149: . PubMed
  10. Lee R, et al. 2022. Cancer Discov. 12:1702. PubMed
  11. Jiang W, et al. 2022. FASEB J. 36:e22294. PubMed
  12. Wang S, et al. 2022. Sci Adv. 8:eabn3883. PubMed
  13. Wu TJ, et al. 2022. Cell Mol Life Sci. 79:348. PubMed
  14. Malhi H, et al. 2022. Cell Rep Med. 3:100658. PubMed
  15. Campisi L, et al. 2022. Nature. 606:945. PubMed
  16. Ma Z, et al. 2022. Theranostics. 12:4965. PubMed
  17. Richards M, et al. 2022. Elife. 11: . PubMed
  18. Gao Y, et al. 2022. Cell Res. 32:1086. PubMed
  19. Ge Y, et al. 2022. iScience. 25:105437. PubMed
  20. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  21. Cattaneo P, et al. 2022. Nat Commun. 13:7444. PubMed
  22. Wang H, et al. 2022. J Nanobiotechnology. 20:513. PubMed
  23. Kuo CS, et al. 2022. Elife. 11: . PubMed
  24. Ge Y, et al. 2022. STAR Protoc. 4:101936. PubMed
  25. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  26. Urata S, et al. 2023. Microbiol Immunol. 67:105. PubMed
  27. Al-Saafeen BH, et al. 2023. Front Immunol. 13:1017780. PubMed
  28. Hu R, et al. 2023. Cell Death Discov. 9:50. PubMed
  29. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  30. Dragan M, et al. 2022. J Invest Dermatol. 142:583. PubMed
  31. Wei J, et al. 2022. Cancer Prev Res (Phila). 15:285. PubMed
  32. Yang Z, et al. 2022. J Nucl Med. 63:1708. PubMed
  33. Xin DQ, et al. 2022. Neural Regen Res. 17:2238. PubMed
  34. Li DD, et al. 2022. Cell Host Microbe. 30:530. PubMed
  35. Bohrer AC, et al. 2022. Cell Rep. 40:111144. PubMed
  36. Yu L, et al. 2022. Cancer Sci. 113:3980. PubMed
  37. Kuo A, et al. 2022. Elife. 11:. PubMed
  38. Chen LC, et al. 2023. Immunology. 169:271. PubMed
  39. Wilson NG, et al. 2023. iScience. 26:105991. PubMed
  40. Peng YJ, et al. 2023. Development. 150:. PubMed
  41. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  42. Pioli KT, et al. 2023. iScience. 26:106223. PubMed
  43. Wu Y, et al. 2023. Nat Cancer. 4:382. PubMed
  44. Henn RE, et al. 2023. iScience. 26:106164. PubMed
  45. Barberio AE, et al. 2023. Bioeng Transl Med. 8:e10453. PubMed
  46. Kawai H, et al. 2023. JBMR Plus. 7:e10722. PubMed
  47. Tan X, et al. 2023. Adv Sci (Weinh). 10:e2206768. PubMed
  48. Palakurthi B, et al. 2023. Nat Commun. 14:2109. PubMed
  49. Yao H, et al. 2023. Front Immunol. 14:1147674. PubMed
  50. Hernandez VG, et al. 2023. Glia. 71:1960. PubMed
  51. Liu H, et al. 2023. Breast Cancer Res. 25:43. PubMed
  52. Petenkova A, et al. 2023. Nat Commun. 14:2761. PubMed
  53. Abdelwahab T, et al. 2023. iScience. 26:106698. PubMed
  54. Shao X, et al. 2023. Cell Discov. 9:44. PubMed
  55. Vereertbrugghen A, et al. 2023. J Neuroinflammation. 20:120. PubMed
  56. Kalgudde Gopal S, et al. 2023. Nat Commun. 14:3020. PubMed
  57. Li M, et al. 2023. BMC Cancer. 23:497. PubMed
  58. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  59. Strickley JD, et al. 2019. Nature. 575:519. PubMed
  60. Jiang Z, et al. 2021. J Clin Invest. 131: . PubMed
  61. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  62. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  63. Kuo PC, et al. 2021. Brain Commun. 3:fcab187. PubMed
  64. Nigam S, et al. 2020. Mol Imaging Biol. 22:685. PubMed
  65. Yang D, et al. 2022. Cell. 185:1905. PubMed
  66. Gavin KM, et al. 2018. Front Endocrinol (Lausanne). 9:276. PubMed
  67. Wang L, et al. 2018. Bone Res. 6:22. PubMed
  68. Cha JH et al. 2018. Molecular cell. 71(4):606-620 . PubMed
  69. Haimon Z et al. 2018. Nature immunology. 19(6):636-644 . PubMed
  70. Ying W, et al. 2019. Cell Metab. 29:457. PubMed
  71. Mourao L, et al. 2019. Sci Rep. 0.991666667. PubMed
  72. Bouchareychas L, et al. 2021. iScience. 24(8):102847. PubMed
  73. Almada AE, et al. 2021. Cell Reports. 34(4):108656. PubMed
  74. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  75. Garcia-Fabiani MB, et al. 2020. Methods Enzymol. 632:369. PubMed
  76. Jaiswal AK, et al. 2020. Immunobiology. 225:151956. PubMed
  77. Cayre S, et al. 2020. Development. 147:00:00. PubMed
  78. Díaz NM, et al. 2020. Invest Ophthalmol Vis Sci. 61:37:00. PubMed
  79. Oetjen LK et al. 2017. Cell. 171(1):217-228 . PubMed
  80. Testini C, et al. 2019. EMBO Rep. 20:e47845. PubMed
  81. Gao Q, et al. 2019. J Exp Med. 216:688. PubMed
  82. Shavit Stein E, et al. 2018. Neural Plast. 2018:7692182. PubMed
  83. Kang I, et al. 2012. Blood. 119:3295. PubMed
  84. Yu K, et al. 2021. Cell Reports. 35(12):109273. PubMed
  85. Lim JT, et al. 2020. Mol Cancer Ther. 1809:19. PubMed
  86. Rosa FF, et al. 2020. Bio Protoc. 10:e3619. PubMed
  87. Wang Y, et al. 2021. J Bone Oncol. 30:100386. PubMed
  88. Lu L, et al. 2022. Sci Rep. 12:931. PubMed
  89. Parhiz H, et al. 2022. J Control Release. 344:50. PubMed
  90. Karlen SJ, et al. 2018. J Neuroinflammation. 15:344. PubMed
  91. Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed
  92. Ahmed M, et al. 2016. Development. 143: 1663 - 1673. PubMed
  93. Chen J, et al. 2022. Nat Commun. 13:6759. PubMed
  94. Wang S, et al. 2022. Front Immunol. 13:869061. PubMed
  95. Engelbrecht E, et al. 2020. eLife. 9:e52690.. PubMed
  96. Hays C, et al. 2020. eLife. 8:e48772.. PubMed
  97. Yu X, et al. 2021. Nature. 594:560. PubMed
  98. Sato S, et al. 2021. Int J Mol Sci. 22:. PubMed
  99. Oliva Chávez AS, et al. 2021. Nat Commun. 12:3696. PubMed
  100. Yanagida K, et al. 2020. Dev Cell. 779:52. PubMed
  101. Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed
  102. Larouche JA, et al. 2021. eLife. 0.416666666666667. PubMed
  103. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  104. Barberio AE, et al. 2020. ACS Nano. 14:11238. PubMed
  105. Zhang Y, et al. 2022. Cancers (Basel). 14:. PubMed
  106. Barwe SP, et al. 2022. J Clin Med. 11:. PubMed
  107. Tilstam PV, et al. 2021. J Clin Invest. 131:. PubMed
  108. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  109. Chiche A, et al. 2016. Oncogene. 10.1038/onc.2016.396. PubMed
  110. Eastman A, et al. 2016. J Immunol . 194: 5999-6010. PubMed
  111. Strunz M, et al. 2020. Nat Commun. 2.929861111. PubMed
  112. Shemer A, et al. 2020. Immunity. 53(5):1033-1049.e7. PubMed
  113. Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
  114. Wosczyna MN, et al. 2021. Cell Stem Cell. 28(7):1323-1334.e8. PubMed
  115. Okuniewska M, et al. 2021. Cell Reports. 36(2):109368. PubMed
  116. Zhao B, et al. 2021. Cell Reports. 36(3):109401. PubMed
  117. Motoyama S, et al. 2020. Cells. :9. PubMed
  118. Park JA, et al. 2021. J Hematol Oncol. 14:142. PubMed
  119. Romagnoli M, et al. 2020. Development. 147:. PubMed
  120. Li Q, et al. 2021. Brain Behav Immun. 94:437. PubMed
  121. Wang X, et al. 2022. Nat Aging. 2:155. PubMed
  122. Wang T, et al. 2020. Blood Sci. 2:79. PubMed
  123. Jin X, et al. 2019. Mol Cell. 73:22:00. PubMed
  124. Duarte N, et al. 2018. Hepatol Commun. 0.833333333. PubMed
  125. Mauduit O, et al. 2022. Front Immunol. 13:1011125. PubMed
  126. Chen Z, et al. 2022. Theranostics. 12:6242. PubMed
  127. Pelletier A, et al. 2012. J Immunol. 188:5561. PubMed
  128. Herting CJ, et al. 2019. Brain. 142:3834. PubMed
  129. Romagnoli M, et al. 2019. Stem Cell Reports. 1.077083333. PubMed
  130. Lv H, et al. 2020. Cell Metabolism. 33(1):110-127.e5. PubMed
  131. Amouyal C, et al. 2020. EBioMedicine. 58:102895. PubMed
  132. Xu X, et al. 2021. J Nanobiotechnology. 19:376. PubMed
  133. Bourn JR, et al. 2021. Cancer Lett. 503:75. PubMed
  134. Khateb M, et al. 2022. Cell Rep. 40:111219. PubMed
  135. Xu Q, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
  136. Liu K, et al. 2022. Theranostics. 12:639. PubMed
  137. Sato Y, et al. 2021. J Clin Invest. Online ahead of print. PubMed
  138. Ning X, et al. 2019. Mol Cell. 74:19. PubMed
  139. De S, et al. 2018. Development. 145. PubMed
  140. Xiao X, et al. 2019. Cell Discov. 5:2. PubMed
  141. Liu L, et al. 2015. Neurol Neuroimmunol Neuroinflamm. 2: 174. PubMed
  142. Hyatt L, et al. 2014. PLoS One. 9:109072. PubMed
  143. Sambasivan R, et al. 2011. Development. 138:3647. PubMed
  144. Ma S, et al. 2021. Cell Reports. 34(6):108726. PubMed
  145. Ankawa R, et al. 2021. Developmental Cell. . PubMed
  146. Hu EY, et al. 2021. Blood Adv. 5:3152. PubMed
  147. Palathingal Bava E, et al. 2022. JCI Insight. 7:. PubMed
  148. An J,et al. 2017. Sci Rep.. 10.1038/s41598-017-13629-0. PubMed
  149. Wosczyna MN et al. 2019. Cell Rep. 27(7):2029-2035 . PubMed
  150. Maston LD, et al. 2017. Am J Physiol Lung Cell Mol Physiol. 312:L609. PubMed
  151. Bresson L, et al. 2018. Development. 145. PubMed
  152. Charmsaz S, et al. 2017. Leukemia. 31:1779. PubMed
  153. Lafkas D, et al. 2013. J Cell Biol. 203:47. PubMed
  154. Kotfis K, et al. 2020. British Journal of Pharmacology. 49(1):66-72. PubMed
  155. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  156. Shcherbina A, et al. 2020. Cell Rep. 32:107964. PubMed
  157. Wu J, et al. 2020. Immunity. 53:115. PubMed
  158. Frii J, et al. 2021. Immunity. 54(5):1002-1021.e10. PubMed
  159. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  160. Fischer A, et al. 2022. Nat Immunol. 23:518. PubMed
  161. Hu J, et al. 2022. Cell Mol Neurobiol. . PubMed
  162. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  163. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  164. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  165. Zheng B, et al. 2018. J Hematol Oncol. 11:16. PubMed
  166. Pal B, et al. 2017. Nat Commun.. 10.1038/s41467-017-01560-x. PubMed
  167. Pezoldt J, et al. 2022. Nat Commun. 13:7227. PubMed
  168. Hou M, et al. 2020. Stem Cell Res Ther. 11:55. PubMed
  169. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  170. Morimoto A, et al. 2021. Nat Commun. 12:2136. PubMed
  171. Hanasoge Somasundara AV, et al. 2021. Cell Rep. 37:110099. PubMed
  172. Thinard R, et al. 2022. Pharmaceutics. 14:. PubMed
  173. Yang H, et al. 2022. Nutrients. 14:. PubMed
  174. Hu J, et al. 2022. J Neuroinflammation. 19:71. PubMed
  175. Yuan Z, et al. 2018. Emerg Microbes Infect. 7:59. PubMed
  176. Crooks SD, et al. 2022. Immunohorizons. 6:705. PubMed
  177. Dudek KA, et al. 2020. Proc Natl Acad Sci U S A. 117:3326. PubMed
  178. Jia Q, et al. 2021. Theranostics. 4699:11. PubMed
  179. Paiva-Oliveira E, et al. 2017. Histochem Cell Biol. 10.1007/s00418-017-1556-6. PubMed
  180. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  181. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  182. Koren E, et al. 2022. Nat Commun. 13:4628. PubMed
  183. Bauer T, et al. 2021. Life (Basel). 11:. PubMed
  184. Li P, et al. 2022. EMBO Mol Med. 14:e14511. PubMed
  185. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  186. Myerson JW, et al. 2021. Nat Nanotechnol. Online ahead of print. PubMed
  187. Bradley KC, et al. 2019. Cell Rep. 28:245. PubMed
  188. Scur M, et al. 2022. Nat Commun. 13:7272. PubMed
  189. Kaur A, et al. 2019. Cancer Discov. 9:64. PubMed
  190. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  191. Zhou G, et al. 2019. FASEB J. 33:11396. PubMed
  192. Mizuno T, et al. 2017. Sci Rep. 7:42714. PubMed
  193. Nosho S, et al. 2020. Int J Mol Sci. 21:00. PubMed
  194. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  195. Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
  196. Yang Y, et al. 2022. Elife. 11:. PubMed
  197. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  198. Zhang Q, et al. 2022. Nat Commun. 13:2406. PubMed
  199. Wang C, et al. 2011. Hepatology. 55:108. PubMed
  200. Sim S, et al. 2016. PLoS One. 11: 0152485. PubMed
  201. Mangum L, et al. 2016. Toxicol Sci. 150: 169 - 177. PubMed
  202. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  203. Xi W, et al. 2021. Stem Cell Res Ther. 167:12. PubMed
  204. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  205. Dawson CA, et al. 2021. Nature Protocols. 16(4):1907-1935. PubMed
  206. Limbad C, et al. 2022. iScience. 25:103848. PubMed
  207. Chiang HY, et al. 2022. Nat Commun. 13:874. PubMed
  208. Aguilera M, et al. 2021. Int J Mol Sci. 22:. PubMed
  209. Tu WL, et al. 2018. Am J Pathol. 188:2688. PubMed
  210. Chiche A, et al. 2019. Breast Cancer Res. 21:13. PubMed
  211. Feng J,et al. 2017. Nat Commun. . 10.1038/s41467-017-01056-8. PubMed
  212. Seki T, et al. 2015. J Biochem. 158: 485 - 495. PubMed
  213. Han Y, et al. 2022. Int J Biol Sci. 18:5653. PubMed
  214. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  215. Liu D, et al. 2020. Front Pharmacol. 11:204. PubMed
  216. Perry JL, et al. 2020. ACS Nano. 5.583333333. PubMed
  217. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  218. Penkert RR, et al. 2020. Obesity (Silver Spring). 1631:28. PubMed
  219. Mori A, et al. 2021. Cells. :10. PubMed
  220. Dion-Albert L, et al. 2022. Nat Commun. 13:164. PubMed
  221. Long JT, et al. 2022. Elife. 11:. PubMed
  222. Zhang Z, et al. 2021. Exp Dermatol. 30:102. PubMed
  223. Echevarría-Vargas IM, et al. 2018. EMBO Mol Med. 10:e8446. PubMed
  224. Shi R, et al. 2019. J Cancer. 10:367. PubMed
  225. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  226. Usmani SM et al. 2019. Cell host & microbe. 25(1):73-86 . PubMed
  227. Zasłona Z, et al. 2017. Am J Physiol Lung Cell Mol Physiol. 312:L855. PubMed
  228. Garcia-Bonilla L, et al. 2014. J Immunol. 193:2531. PubMed
  229. Ding X, et al. 2015. J Immunol. 194:4251. PubMed
  230. Wang L, et al. 2015. Cancer Immunol Res. 3: 1030-1041. PubMed
  231. Mueller A, et al. 2016. Nature. 540:276-279. PubMed
  232. Cai B, et al. 2020. Cell Metabolism. 31(2):406-421.e7.. PubMed
  233. Lu Y, et al. 2020. Immunity. 52:782. PubMed
  234. Murdock BJ, et al. 2021. JCI Insight. 6:. PubMed
  235. Yang Y, et al. 2021. Cell Reports. 34(10):108822. PubMed
  236. Taya M, et al. 2020. Endocr Relat Cancer. 27:261. PubMed
  237. Saber M, et al. 2021. J Neurosci Res. 99:1136. PubMed
  238. Takaku S, et al. 2022. Evid Based Complement Alternat Med. 2022:6122955. PubMed
  239. Toyama K, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1392. PubMed
  240. Qiao S, et al. 2019. J Neuroinflammation. 16:4. PubMed
  241. Hoover AR, et al. 2022. Clin Transl Med. 12:e937. PubMed
  242. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  243. Yeo SK, et al. 2020. eLife. 9:e58810.. PubMed
  244. Deng P, et al. 2021. Cell Stem Cell. 28(6):1057-1073.e7. PubMed
  245. Zhang Y, et al. 2020. Cancer Res. 80:3345. PubMed
  246. Zhang J, et al. 2022. Biomater Res. 26:44. PubMed
  247. Carmody C et al. 2019. Endocrinology. 160(5):1205-1222 . PubMed
  248. Fu NY, et al. 2018. Dev Cell. 47:629. PubMed
  249. Elias S, et al. 2015. PLoS Biol. 13:1002142. PubMed
  250. Nasser H, et al. 2020. Cell Death Discov. 0.29375. PubMed
  251. Sroor HM, et al. 2019. Sci Rep. 9:20217. PubMed
  252. Chen PY, et al. 2019. Nat Metab. 0.675. PubMed
  253. Bagati A, et al. 2020. Cancer Cell. 39(1):54-67.e9. PubMed
  254. Zheng Y, et al. 2022. J Immunol. 208:501. PubMed
  255. Cao Y, et al. 2019. Nat Commun. 10:1280. PubMed
  256. Liu L et al. 2018. Cell stem cell. 23(4):544-556 . PubMed
  257. Kim KS, et al. 2022. JCI Insight. 7:. PubMed
  258. Zhang T, et al. 2020. JCI Insight. 5:00. PubMed
  259. Cai T, et al. 2022. Nat Commun. 13:2228. PubMed
  260. Porrello A, et al. 2018. Nat Commun. 9:1988. PubMed
  261. Gopalakrishnapillai A, et al. 2021. Cancers (Basel). 13:. PubMed
  262. Pal B, et al. 2021. Breast Cancer Res. 23:69. PubMed
  263. Maller O, et al. 2020. Nat Mater. 20:548. PubMed
  264. Saber M, et al. 2020. Eur J Neurosci. 52:2791. PubMed
  265. Liu G, et al. 2022. Theranostics. 12:2248. PubMed
  266. Piirainen S, et al. 2021. Glia. 69:2459. PubMed
  267. Arora S, et al. 2021. Med (N Y). 2:938. PubMed
  268. Li H, et al. 2022. iScience. 25:104481. PubMed
  269. Cayre S, et al. 2020. Development. . PubMed
  270. Endo-Umeda K, et al. 2021. Sci Rep. 11:22595. PubMed
  271. Ortiz A, et al. 2019. Cancer Cell. 35:33:00. PubMed
  272. Ouadah Y, et al. 2019. Cell. 179:403. PubMed
  273. Piotrowski AF, et al. 2018. Oncoimmunology. 7:e1445951. PubMed
  274. Sarshad AA, et al. 2018. Mol Cell. 71:1040. PubMed
  275. Vaas M, et al. 2016. J Cereb Blood Flow Metab. 10.1177/0271678X16676825. PubMed
  276. Wong J, et al. 2016. Sci Signal. 9: ra103. PubMed
  277. Yuan Z, et al. 2016. J Virol. 90: 7728 - 7739. PubMed
  278. Garcia-Bonilla L, et al. 2015. J Neurosci. 35: 14783 - 14793. PubMed
  279. Jiang Y, et al. 2015. MBio. 6: e01426-15. PubMed
  280. Roberts L, et al. 2014. Infect Immun . 82:2504. PubMed
  281. Qu Y, et al. 2020. Cell Reports. 32(1):107873. PubMed
  282. Jaeger N, et al. 2020. Cell Rep. 33:108331. PubMed
  283. Koh BI, et al. 2020. Nat Commun. 3.143055556. PubMed
  284. Ren D, et al. 2020. Am J Cancer Res. 2851:10. PubMed
  285. Hu Y, et al. 2021. J Nanobiotechnology. 19:416. PubMed
  286. Kastenschmidt JM, et al. 2021. Cell Rep. 35:108997. PubMed
  287. Su M, et al. 2018. Immunol Cell Biol. 9:2448. PubMed
  288. Wunderlich CM, et al. 2018. Nat Commun. 9:1646. PubMed
  289. Peltzer N, et al. 2018. Nature. 557:112. PubMed
  290. Quijano-Rubio A, et al. 2022. Nat Biotechnol. Online ahead of print. PubMed
  291. Scheyltjens I, et al. 2022. Nat Protoc. 17:2354. PubMed
  292. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  293. Dai B, et al. 2021. Cell Reports Medicine. 2(8):100381. PubMed
  294. Bravo JI, et al. 2021. STAR Protocols. 2(2):100406. PubMed
  295. Liu C, et al. 2022. Nat Commun. 13:1989. PubMed
  296. Saber M, et al. 2021. J Neurotrauma. 38:2862. PubMed
  297. Wang Y, et al. 2022. Nat Cell Biol. 24:230. PubMed
  298. Okubo A, et al. 2021. Int J Mol Sci. 23:. PubMed
  299. Deets KA, et al. 2021. Elife. 10:. PubMed
  300. Murray CW, et al. 2022. Nat Commun. 13:1090. PubMed
  301. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  302. Zhong J, et al. 2021. Commun Biol. 4:865. PubMed
  303. Kabir AU, et al. 2018. JCI Insight. 3. PubMed
  304. Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed
RRID
AB_312976 (BioLegend Cat. No. 103111)
AB_312977 (BioLegend Cat. No. 103112)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine5 anti-mouse CD45 30-F11 FC
PE anti-mouse CD45 30-F11 FC
PE/Cyanine7 anti-mouse CD45 30-F11 FC
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark Blue™ 515 anti-mouse CD45 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
PE/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark PLUS UV395™ anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 30-F11 FC
Spark YG™ 581 anti-mouse CD45 (Flexi-Fluor™) 30-F11 FC
Spark PLUS V475™ anti-mouse CD45 Antibody 30-F11 FC
StarBright UltraViolet 740 anti-mouse CD45 30-F11 FC
Go To Top Version: 2    Revision Date: 05/14/2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account